Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

3 High-Yield Stocks Still Worth Buying


3 High-Yield Stocks Still Worth Buying

Who doesn't like free money? While they may be somewhat forgotten as the stock market hits seemingly one new high after another, high-yield dividend stocks play an important role in providing steady income for retirees and helping investors hedge against inevitable stock market declines.

But not all high-yield stocks are created equal. Some have fallen in recent quarters as a result of genuine concerns about their business models, while others have simply been given a bad rap. It's this latter group that could be worth a closer inspection. 

According to three of our Foolish investors, coal producer Alliance Resource Partners (NASDAQ: ARLP), massive retail chain Target Corporation (NYSE: TGT), and U.K.-based pharma giant GlaxoSmithKline (NYSE: GSK), are three high-yield stocks that may still be worth buying. 

Continue reading


Source: Fool.com

GSK plc ADR Aktie

41,60 €
-0,48 %
Die GSK plc ADR Aktie zeigt heute einen leichten Rückgang von -0,48 %.

Like: 0
GSK
Teilen

Kommentare